A LinkedIn post from ABM Respiratory Care highlights the company’s participation in the 1st Annual Wisconsin Respiratory Education Symposium (WiRES 2026) in Wisconsin Dells from April 19–21. The post indicates ABM will host a booth showcasing its BiWaze platform for airway clearance therapy, with live demonstrations led by representative Theresa Reger.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to the post, attendees can see real-time demos of the BiWaze Cough and BiWaze Clear systems, which feature dual blower technology for bi-directional control of inhalation and exhalation. The content also notes that ABM plans to present insights into new clinical studies related to mucus mobilization and improved aerosol deposition, and provides links for additional information and demo scheduling for those unable to attend.
For investors, the post suggests ABM is actively engaging with respiratory therapists and clinical stakeholders at a specialized education event, potentially supporting clinician awareness and adoption of the BiWaze platform. If these demos and referenced clinical insights translate into greater clinical validation and utilization, they could strengthen ABM’s competitive position in the respiratory care and airway clearance market and support future revenue growth.
The emphasis on hospital-to-home support in the post also points to ABM’s focus on care continuum solutions, which aligns with broader health system trends toward out-of-hospital management of chronic respiratory conditions. This strategy may position the company to benefit from demand for technologies that reduce hospital utilization, though the post does not provide details on commercial traction, pricing, or financial impact at this stage.